Jazz Pharmaceuticals (JAZZ) Reports Submission of Marketing Authorization Application to European Medicines Agency for Solriamfetol
Tweet Send to a Friend
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
